• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持基于癌症治疗后监测结果信息的共享决策:SHOUT-BC 研究结果。

Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study.

机构信息

University of Twente, Department of Health Technology and Services Research, Technical Medical Centre, Enschede, the Netherlands; Santeon, Utrecht, the Netherlands.

University of Twente, Department of Psychology, Health & Technology, Enschede, the Netherlands.

出版信息

Eur J Cancer. 2024 Dec;213:115107. doi: 10.1016/j.ejca.2024.115107. Epub 2024 Nov 2.

DOI:10.1016/j.ejca.2024.115107
PMID:39504676
Abstract

BACKGROUND

Integrating outcome information into the process of shared decision-making (SDM) about post-treatment surveillance can enhance its effectiveness. The Breast Cancer Surveillance Decision Aid (BCS-PtDA) integrates risk estimations of patients' risks for recurrences as well as outcome information on fear of cancer recurrence (FCR). The SHOUT-BC study aimed to evaluate the effectiveness of the implementation of the BCS-PtDA. Patients' satisfaction with the BCS-PtDA was also evaluated.

METHODS

As described in a previously published protocol paper, the study employed a Prospective multiple interrupted time series (ITS) design in which the BCS-PtDA was implemented stepwise into the care pathways of eight Dutch hospitals.

RESULTS

A total of 507 participants completed a questionnaire after their first surveillance consultation which usually takes place approximately one year after surgery. ITS analysis per hospital and subsequent meta-analysis over hospital effects indicated a significant increase in patient-reported SDM from pre- to post-implementation (overall estimated effect: 27.14, 95 % CI: 22.71 to 31.87, p < .0001). Moreover, post-implementation participants (n = 225) reported a more active role in decision-making, decreased decisional conflict, and increased knowledge on the aim and methods of surveillance. Furthermore, a decrease in FCR was seen post-implementation. The self-reported intensity of surveillance schedules decreased slightly and the BCS-PtDA received highly positive evaluations.

DISCUSSION

The implementation of the BCS-PtDA, which integrates outcome information, led to increased patient-reported SDM and an improved quality of decision-making. The BCS-PtDA was evaluated highly positively by participants. Further research should address optimisation of the implementation.

摘要

背景

将预后信息纳入治疗后监测的共同决策(SDM)过程中,可以提高其效果。乳腺癌监测决策辅助工具(BCS-PtDA)整合了患者复发风险的估计以及对癌症复发恐惧(FCR)的预后信息。SHOUT-BC 研究旨在评估 BCS-PtDA 的实施效果。同时还评估了患者对 BCS-PtDA 的满意度。

方法

正如之前发表的方案论文所述,该研究采用前瞻性多个中断时间序列(ITS)设计,逐步将 BCS-PtDA 实施到 8 家荷兰医院的护理路径中。

结果

共有 507 名参与者在第一次监测咨询后完成了一份问卷,第一次监测咨询通常在手术后大约一年进行。对每家医院进行 ITS 分析,并对医院间的效果进行荟萃分析,结果表明,患者报告的 SDM 从实施前到实施后有显著增加(总体估计效果:27.14,95%CI:22.71 至 31.87,p<0.0001)。此外,实施后组(n=225)报告在决策中发挥更积极的作用,决策冲突减少,对监测目的和方法的认识增加。此外,实施后 FCR 下降。自我报告的监测计划强度略有下降,BCS-PtDA 获得了高度积极的评价。

讨论

将预后信息纳入其中的 BCS-PtDA 的实施提高了患者报告的 SDM 和决策质量。参与者对 BCS-PtDA 的评价非常积极。进一步的研究应解决实施的优化问题。

相似文献

1
Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study.支持基于癌症治疗后监测结果信息的共享决策:SHOUT-BC 研究结果。
Eur J Cancer. 2024 Dec;213:115107. doi: 10.1016/j.ejca.2024.115107. Epub 2024 Nov 2.
2
Evaluation of the Implementation of the Dutch Breast Cancer Surveillance Decision Aid including Personalized Risk Estimates in the SHOUT-BC Study: A Mixed Methods Approach.在SHOUT-BC研究中对荷兰乳腺癌监测决策辅助工具(包括个性化风险评估)实施情况的评估:一种混合方法研究。
Cancers (Basel). 2024 Mar 31;16(7):1390. doi: 10.3390/cancers16071390.
3
Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination With a Mixed Methods Design.通过个性化复发风险计算支持乳腺癌术后监测的共同决策:结合国际患者决策辅助工具标准制定流程和混合方法设计开发患者决策辅助工具
JMIR Cancer. 2022 Nov 14;8(4):e38088. doi: 10.2196/38088.
4
Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.基于结局信息的共享决策支持在乳腺癌、中风和晚期肾病患者中的效果及实施:一项多组间中断时间序列研究的 SHOUT 方案
BMJ Open. 2022 Aug 1;12(8):e055324. doi: 10.1136/bmjopen-2021-055324.
5
The impact of a patient decision aid on shared decision-making behaviour in oncology care and pulmonary medicine-A field study based on real-life observations.患者决策辅助工具对肿瘤学和肺病学护理中共同决策行为的影响-基于真实观察的现场研究。
J Eval Clin Pract. 2019 Dec;25(6):1121-1130. doi: 10.1111/jep.13196. Epub 2019 May 29.
6
A novel patient decision aid for aftercare in breast cancer patients: A promising tool to reduce costs by individualizing aftercare.一种新的乳腺癌患者康复后护理决策辅助工具:通过个性化康复后护理降低成本的有前景的工具。
Breast. 2018 Oct;41:144-150. doi: 10.1016/j.breast.2018.06.015. Epub 2018 Jul 18.
7
Elicitation of preferences in the second half of the shared decision making process needs attention; a qualitative study.在共同决策过程的后半阶段引出偏好需要关注:一项定性研究。
BMC Health Serv Res. 2020 Jul 9;20(1):635. doi: 10.1186/s12913-020-05476-z.
8
Does lack of deeper understanding of shared decision making explains the suboptimal performance on crucial parts of it? An example from breast cancer care.对共同决策缺乏更深入的理解是否可以解释在其关键部分的表现欠佳?以乳腺癌护理为例。
Eur J Oncol Nurs. 2019 Feb;38:92-97. doi: 10.1016/j.ejon.2018.12.004. Epub 2018 Dec 15.
9
Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.发展考虑保乳术后放疗的Ⅰ期乳腺癌老年女性患者的决策辅助工具。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):30-8. doi: 10.1016/j.ijrobp.2011.11.028. Epub 2012 Feb 11.
10
A prospective cohort study of shared decision making in lung cancer diagnostics: Impact of using a patient decision aid.一项关于肺癌诊断中共享决策的前瞻性队列研究:使用患者决策辅助工具的影响。
Patient Educ Couns. 2019 Nov;102(11):1961-1968. doi: 10.1016/j.pec.2019.05.018. Epub 2019 May 16.

引用本文的文献

1
Shared decision-making for early-stage breast cancer treatment: An evolutionary concept analysis.早期乳腺癌治疗的共同决策:一项概念演变分析
Asia Pac J Oncol Nurs. 2025 Aug 19;12:100775. doi: 10.1016/j.apjon.2025.100775. eCollection 2025 Dec.
2
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.INFLUENCE 3.0模型:局部区域复发和对侧乳腺癌的更新预测,现在也适用于接受新辅助全身治疗的患者。
Breast. 2025 Feb;79:103829. doi: 10.1016/j.breast.2024.103829. Epub 2024 Oct 28.
3
Evaluation of the Implementation of the Dutch Breast Cancer Surveillance Decision Aid including Personalized Risk Estimates in the SHOUT-BC Study: A Mixed Methods Approach.
在SHOUT-BC研究中对荷兰乳腺癌监测决策辅助工具(包括个性化风险评估)实施情况的评估:一种混合方法研究。
Cancers (Basel). 2024 Mar 31;16(7):1390. doi: 10.3390/cancers16071390.